Biography
I am a solid organ transplant clinical pharmacist specialist. I primarily work in the kidney transplant clinics but also rotate within the solid organ transplant pharmacy team.
Pharmacy School Attended: Creighton (2015)
Other Training:
- PGY1 Pharmacy: Saint Luke’s Hospital, Kansas City, MO (2016)
- PGY2 Solid Organ Transplant: University of Utah, Salt Lake City, UT (2017)
Areas of Interest
Immunosuppression, Viral Infections –BK, CMV, EBV, Adherence, QI initiatives
Published Articles or Reviews
- Bixby AL, Shaikh AS, Naik AS, CotigualaL, McMurry K, Samaniego-Picota M, Marshall V, Park JM. Safety and Efficacy of direct-acting oral anticoagulants versus warfarin in kidney transplant recipients: a retrospective single-center cohort study. Transplant International. 2020; 33:740-751.
- Cotiguala L, Coover K, Bewtra A, Malesker M. Advances in the Pharmacotherapy of Hereditary Angioedema. U.S. Pharmacist. 2015; 40 (10):17-21.
- Ky TQ, Cotiguala L, Fitzgerald L, McMurry K, Park J, Tischer S. Comparison of oropharyngeal candidiasis outcomes in renal transplant recipients receiving nystatin or no antifungal prophylaxis. Am J Transplant2020; 20(s3):373.(Oral Abstract)
- Cotiguala L, Masood A, Park J, NaikA. Increasing Net Immunosuppression after BK Viremia [abstract]. Am J Transplant. 2019; 19 (Oral Abstract)
- Bixby AL, Fitzgerald L, Cotiguala L, Park J, Kaul D, Sonnenday C, Tischer S. Comparison of Two Dosing Regimens of Valganciclovir for CytomegalovirusProphylaxis in High-Risk Liver Transplant Recipients [abstract]. Am J Transplant. 2019; 19 (suppl 3).
- Cotiguala L, Carlson A, Truax C, Sirandas B, Hall I, Smith L. Immediate vs Delayed Initiation of CMV Prophylaxis...Safe and Cost Beneficial? [abstract]. AmJ Transplant. 2017; 17 (suppl 3).
- Cahill B, Liou T, Peterson-Short K, Maughan T, Doidge W, Sirandas B, Carlson A, Truax C, Cotiguala L, Raman S, McKellar S, Selzman C. Post-Lung Transplant Survival After Venous Thromboembolism [S403]. J Heart Lung Transplant. 2017; 36 (suppl 4).
- Collier J, Cotiguala L, Wills M. Should Bleomycin test dosing still be performed? [133]. Pharmacotherapy. 2016; 36 (7) e122.